These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35936010)

  • 1. TRAPS mutations in
    Akagi T; Hiramatsu-Asano S; Ikeda K; Hirano H; Tsuji S; Yahagi A; Iseki M; Matsuyama M; Mak TW; Nakano K; Ishihara K; Morita Y; Mukai T
    Front Immunol; 2022; 13():926175. PubMed ID: 35936010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
    Tsuji S; Matsuzaki H; Iseki M; Nagasu A; Hirano H; Ishihara K; Ueda N; Honda Y; Horiuchi T; Nishikomori R; Morita Y; Mukai T
    Clin Exp Immunol; 2019 Dec; 198(3):416-429. PubMed ID: 31429073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.
    Simon A; Park H; Maddipati R; Lobito AA; Bulua AC; Jackson AJ; Chae JJ; Ettinger R; de Koning HD; Cruz AC; Kastner DL; Komarow H; Siegel RM
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9801-6. PubMed ID: 20457915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).
    Bachetti T; Chiesa S; Castagnola P; Bani D; Di Zanni E; Omenetti A; D'Osualdo A; Fraldi A; Ballabio A; Ravazzolo R; Martini A; Gattorno M; Ceccherini I
    Ann Rheum Dis; 2013 Jun; 72(6):1044-52. PubMed ID: 23117241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).
    Negm OH; Mannsperger HA; McDermott EM; Drewe E; Powell RJ; Todd I; Fairclough LC; Tighe PJ
    Eur J Immunol; 2014 Jul; 44(7):2096-110. PubMed ID: 24668260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
    Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
    J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant.
    Siebert S; Amos N; Fielding CA; Wang EC; Aksentijevich I; Williams BD; Brennan P
    Arthritis Rheum; 2005 Apr; 52(4):1287-92. PubMed ID: 15818692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three
    Harrison SR; Scambler T; Oubussad L; Wong C; Wittmann M; McDermott MF; Savic S
    Front Immunol; 2018; 9():173. PubMed ID: 29467762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).
    Lobito AA; Kimberley FC; Muppidi JR; Komarow H; Jackson AJ; Hull KM; Kastner DL; Screaton GR; Siegel RM
    Blood; 2006 Aug; 108(4):1320-7. PubMed ID: 16684962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.
    Caminero A; Comabella M; Montalban X
    Clin Exp Immunol; 2011 Dec; 166(3):338-45. PubMed ID: 22059991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.
    Rittore C; Méchin D; Sanchez E; Marinèche L; Ea V; Soler S; Vereecke M; Mallavialle A; Richard E; Duroux-Richard I; Apparailly F; Touitou I; Grandemange S
    Sci Rep; 2021 Feb; 11(1):4172. PubMed ID: 33603056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
    Cudrici C; Deuitch N; Aksentijevich I
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders.
    Jéru I; Charmion S; Cochet E; Copin B; Duquesnoy P; Garcia MT; Le Borgne G; Cathebras P; Gaillat J; Karabina S; Dodé C; Lohse P; Hentgen V; Amselem S
    PLoS One; 2013; 8(7):e69757. PubMed ID: 23894535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing.
    Todd I; Negm OH; Reps J; Radford P; Figueredo G; McDermott EM; Drewe E; Powell RJ; Bainbridge S; Hamed M; Crouch S; Garibaldi J; St-Gallay S; Fairclough LC; Tighe PJ
    Pharmacol Res; 2017 Nov; 125(Pt B):188-200. PubMed ID: 28860008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Setting up TRAPS.
    Pettersson T; Kantonen J; Matikainen S; Repo H
    Ann Med; 2012 Mar; 44(2):109-18. PubMed ID: 21284532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene.
    Rittore C; Sanchez E; Soler S; Barat-Houari M; Albers M; Obici L; McDermott MF; Touitou I; Grandemange S
    Ann Rheum Dis; 2014 Jan; 73(1):290-7. PubMed ID: 23505244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome.
    Dickie LJ; Aziz AM; Savic S; Lucherini OM; Cantarini L; Geiler J; Wong CH; Coughlan R; Lane T; Lachmann HJ; Hawkins PN; Robinson PA; Emery P; McGonagle D; McDermott MF
    Ann Rheum Dis; 2012 Dec; 71(12):2035-43. PubMed ID: 22679299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS).
    Churchman SM; Church LD; Savic S; Coulthard LR; Hayward B; Nedjai B; Turner MD; Mathews RJ; Baguley E; Hitman GA; Gooi HC; Wood PM; Emery P; McDermott MF
    Ann Rheum Dis; 2008 Nov; 67(11):1589-95. PubMed ID: 18086728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
    Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S
    Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.